ATE512230T1 - Proteinherstellungsverfahren unter nutzung von yebf - Google Patents

Proteinherstellungsverfahren unter nutzung von yebf

Info

Publication number
ATE512230T1
ATE512230T1 AT05774845T AT05774845T ATE512230T1 AT E512230 T1 ATE512230 T1 AT E512230T1 AT 05774845 T AT05774845 T AT 05774845T AT 05774845 T AT05774845 T AT 05774845T AT E512230 T1 ATE512230 T1 AT E512230T1
Authority
AT
Austria
Prior art keywords
protein
fusion protein
yebf
polypeptide
further comprise
Prior art date
Application number
AT05774845T
Other languages
German (de)
English (en)
Inventor
Joel Weiner
Guijin Zhang
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Application granted granted Critical
Publication of ATE512230T1 publication Critical patent/ATE512230T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05774845T 2004-08-18 2005-08-12 Proteinherstellungsverfahren unter nutzung von yebf ATE512230T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52212504P 2004-08-18 2004-08-18
PCT/CA2005/001249 WO2006017929A1 (en) 2004-08-18 2005-08-12 Protein production method utilizing yebf

Publications (1)

Publication Number Publication Date
ATE512230T1 true ATE512230T1 (de) 2011-06-15

Family

ID=35907194

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05774845T ATE512230T1 (de) 2004-08-18 2005-08-12 Proteinherstellungsverfahren unter nutzung von yebf

Country Status (7)

Country Link
US (1) US20060246539A1 (enExample)
EP (1) EP1791961B1 (enExample)
JP (1) JP2008509682A (enExample)
AT (1) ATE512230T1 (enExample)
AU (1) AU2005274628A1 (enExample)
CA (1) CA2576083A1 (enExample)
WO (1) WO2006017929A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006050332A1 (de) 2006-10-25 2008-04-30 Wacker Chemie Ag DNS-Konstrukt und Verfahren zur fermentativen Herstellung von Fusionsproteinen
AU2012253359B2 (en) * 2011-05-11 2017-06-08 Children's Medical Center Corporation Multiple antigen presenting immunogenic composition, and methods and uses thereof
CA2900008C (en) 2013-02-07 2025-10-07 Children's Medical Center Corporation PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10435697B2 (en) * 2014-11-03 2019-10-08 Nanyang Technological University Recombinant expression system that senses pathogenic microorganisms
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11365225B2 (en) 2015-11-19 2022-06-21 President And Fellows Of Harvard College Method of making recombinant silk and silk-amyloid hybrid proteins using bacteria
US12351805B2 (en) 2015-11-19 2025-07-08 Northeastern University Method of making recombinant silk and silk-amyloid hybrid proteins using bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
EP3600400A4 (en) 2017-03-28 2021-01-13 The Children's Medical Center Corporation MULTIPLE ANTIGEN PRESENTATION SYSTEM (MAPS) BASED STAPHYLOCOCCUS AUREUS VACCINE, IMMUNOGEN COMPOSITION AND THEIR USES
CN111065417B (zh) 2017-06-23 2024-04-19 美商艾芬尼维克斯公司 免疫原性组合物
TW202019470A (zh) 2018-09-12 2020-06-01 美商艾芬尼維克斯公司 多價肺炎球菌疫苗
KR102922338B1 (ko) 2018-09-12 2026-02-05 더 칠드런스 메디칼 센터 코포레이션 폐렴구균 융합 단백질 백신
CN113383080B (zh) * 2019-02-15 2024-05-14 昂科斯密斯生物技术私人有限公司 用于增加蛋白质分泌的细菌表达载体
JP7487951B2 (ja) * 2019-02-24 2024-05-21 オンコシミス バイオテック プライベート リミテッド 細菌による組換えglp-1ペプチドの連続生産方法
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins
WO2023039223A1 (en) 2021-09-09 2023-03-16 Affinivax, Inc. Multivalent pneumococcal vaccines

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335357C (en) * 1987-10-30 1995-04-25 Timothy M. Rose Expression systems for preparation of polypeptides in prokaryotic cells
US5646016A (en) * 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
US6033877A (en) * 1995-11-02 2000-03-07 Research Foundation Of State University Of New York Peptide expression and delivery system
US6022952A (en) * 1998-04-01 2000-02-08 University Of Alberta Compositions and methods for protein secretion
US6733997B1 (en) * 1998-10-30 2004-05-11 National University Of Singapore Isolated nucleic acids encoding a secretory signal for expression and secretion of heterologous recombinant proteins
FI109361B (fi) 1999-05-04 2002-07-15 Korpela Timo Mikrobinen proteiinin ilmentämisjärjestelmä
AU2001261242B2 (en) * 2000-05-03 2006-12-14 Expressive Constructs, Inc. A method for improving recombinant protein stability and solubility
EP1343870A4 (en) * 2000-11-09 2005-07-13 Univ Queensland BACTERIAL EXPRESSION
US20040142429A1 (en) * 2001-01-25 2004-07-22 Grant Chris W.M. Method for the expression, purification, and structure recovery and handling of hydrophobic proteins, polypeptides or peptides
JP2004532033A (ja) * 2001-05-04 2004-10-21 コーネル リサーチ ファンデイション インコーポレイテッド 発現し難いタンパク質用の迅速に開裂可能なsumo融合タンパク質発現系
KR100447530B1 (ko) * 2001-08-14 2004-09-08 한국과학기술원 OmpF를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법
US6790051B1 (en) * 2003-12-20 2004-09-14 Lear Corporation Connector for printed circuit board

Also Published As

Publication number Publication date
CA2576083A1 (en) 2006-02-23
EP1791961B1 (en) 2011-06-08
US20060246539A1 (en) 2006-11-02
JP2008509682A (ja) 2008-04-03
EP1791961A4 (en) 2008-11-19
EP1791961A1 (en) 2007-06-06
AU2005274628A1 (en) 2006-02-23
WO2006017929A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
ATE512230T1 (de) Proteinherstellungsverfahren unter nutzung von yebf
AR110864A2 (es) Procesos para cultivos celulares
MY161892A (en) A method of obtaining a purified, biologically active heterologous protein
ATE426674T1 (de) Stoffwechselanderungen in garungen zur produktion rekombinanter proteine
DK1422237T3 (da) Fremgangsmåder til rekombinant frembringelse af antifusogene peptider
WO2002099067A3 (en) Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
EA200600946A1 (ru) Способы продуцирования аполипопротеинов в трансгенных растениях
DE60227653D1 (de) Verfahren zur herstellung von l-aminosäuren, unter verwendung von stämmen aus der familie der enterohalten
DE69906509D1 (de) Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen
ATE486935T1 (de) Mikroorganismenstamm zur produktion von rekombinanten proteinen
JP2008509682A5 (enExample)
WO2005026375A3 (en) Recombinant carrier molecule for expression, delivery and purification of target polypeptides
ATE298794T1 (de) Verfahren zur herstellung und reinigung von sekretierten proteinen und herstellung von protein-arrays
DE602004025011D1 (de) Verfahren zur herstellung rekombinanter proteine
ATE542913T1 (de) Promotorvarianten zur expression von genen in einer pilzzelle
ATE408016T1 (de) Verfahren zur herstellung und sekretion modifizierter peptide
DE60334109D1 (de) Yapsin-mangelmutantenstamm von hansenula polymorpha sowie verfahren zur herstellung rekombinanter proteine damit
MXPA05012336A (es) Procedimiento para producir una proteina dirigida a un plastidio en celulas vegetales.
WO2005021764A3 (en) A process for proteolytic cleavage and purification of recombinant proteins produced in plants
DK1905839T3 (da) Fremgangsmåde til fermentativ fremstilling af proteiner
ATE335826T1 (de) Proteinherstellung
DE602004023408D1 (de) Agments unter verwendung einer e.coli-signalsequenz sowie verfahren zur massenproduktion des antikörperfragments
DE60021404D1 (de) System zur herstellung von proteinen
DE60219361D1 (de) Verfahren zur rekombinanten herstellung von plazenta wachstumsfaktor
RU2015105274A (ru) СПОСОБ ПОЛУЧЕНИЯ БЕЛКОВ СЕМЕЙСТВА ЦИСТЕИНОВЫХ ПРОТЕАЗ ПШЕНИЦЫ (Triticum aestivum) И ПРЕПАРАТ БЕЛКА ТРИТИКАИН-АЛЬФА, ПОЛУЧЕННЫЙ ЭТИМ СПОСОБОМ

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties